Trending Now
Nantkwest Inc (NASDAQ: NK) And ImmunityBio Ink Collaborative Deal For Joint...
Nantkwest Inc (NASDAQ:NK) and ImmunityBio have announced that they have entered into a joint agreement to work together on the development, manufacturing, and marketing...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Crypto Stocks Enter a New Age (CAN, RIOT, ISWH, MARA)
The Cryptocurrency boom that got full-throated traction last fall has only accelerated, and the key point in play is legitimacy.
MAKE IT MODERN
LATEST REVIEWS
Clovis Oncology Inc. (NASDAQ:CLVS) Reports Q3 2020 Results With Rubraca Sales...
Clovis Oncology Inc. (NASDAQ:CLVS) has announced results for Q3 2020 and also offers an update on its clinical development programs and commercial outlook for...
MAKE IT MODERN
PERFORMANCE TRAINING
Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX) Reports Topline Data For ATTACK Study Evaluating SUL-DUR’s...
Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX) has reported topline data from the ATTACK study. ATTACK trial is a global third phase registration study assessing...
ABVC BioPharma Inc. (NASDAQ: ABVC) Announces Q3 2021 Net loss of $1.9M and Nasdaq...
ABVC BioPharma Inc. (NASDAQ: ABVC) has announced its operating and financial Q3 2021, ending September 30, 2021.
Q3 revenue of $98,999
Revenue in Q3 2021 was...
Evofem Biosciences Inc.’s (NASDAQ: EVFM) Phexxi Access Expanded Under New Guidelines With No Out-of-Pocket...
Evofem Biosciences Inc. (NASDAQ: EVFM) has applauded the United States Department of Labour and Health Resources and Services Administration (HRSA) for issuing updated contraceptive...
Moderna Inc (NASDAQ:MRNA) Clinches A Deal For $1.525 Billion To Supply 100 Million Doses...
Moderna Inc (NASDAQ:MRNA) received an order from the US Government to supply 100 million doses of its mRNA-1273 vaccine. The US Government can also...
Investors Focus on Top Metaverse Plays as New Year Gets in Gear (U, EPAZ,...
The investing landscape for 2022 is uncertain, as we have seen over recent days. The year has started with selling driven by...
MAKE IT MODERN
